FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Helmut Schrott

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Physiology

Postmenopause

Co-author Network

Publications

TOP 3
Jennifer G Robinson; Helmut Schrott
Statin pleiotropy: a popular concept but clinical significance unclear.
Jennifer G Robinson; Brian Smith; Nidhi Maheshwari; Helmut Schrott
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
Theodore Feldman; Michael J Koren; William Insull; James McKenney; Helmut Schrott; Andrew Lewin; Sukrut Shah; Michelle Sidisin; Meehyung Cho; Debra Kush; Yale B Mitchel
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Helmut Schrott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Jennifer G Robinson; Helmut Schrott
Statin pleiotropy: a popular concept but clinical significance unclear.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(2):81-3.
2005: Jennifer G Robinson; Brian Smith; Nidhi Maheshwari; Helmut Schrott
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
Journal of the American College of Cardiology 2005;46(10):1855-62.
2004: Theodore Feldman; Michael J Koren; William Insull; James McKenney; Helmut Schrott; Andrew Lewin; Sukrut Shah; Michelle Sidisin; Meehyung Cho; Debra Kush; Yale B Mitchel
Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
The American journal of cardiology 2004;93(12):1481-6.
2004: William Insull; Mark E McGovern; Helmut Schrott; Paul Thompson; John R Crouse; Franklin Zieve; John Corbelli
Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.
Archives of internal medicine 2004;164(10):1121-7.
2003: Harold E Bays; James M McKenney; Carlos A Dujovne; Helmut Schrott; Michael J Zema; Jack Nyberg; Diane E MacDougall
Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
The American journal of cardiology 2003;92(5):538-43.
2003: Jonathan L Isaacsohn; Donald B Hunninghake; Helmut Schrott; Carlos A Dujovne; Robert Knopp; Stuart R Weiss; Harold E Bays; John R Crouse; Michael H Davidson; Leonard M Keilson; James McKenney; Stanley G Korenman; Adrian S Dobs; Evan Stein; Ronald M Krauss; Darbie Maccubbin; Meehyung Cho; Diane J Plotkin; Yale B Mitchel
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
Clinical cardiology 2003;26(1):18-24.
2002: Stephen B Hulley; Curt D Furberg; Elizabeth Barrett-Connor; Jane A Cauley; Deborah Grady; William Haskell; Robert Knopp; Maureen H Lowery; Suzanne Satterfield; Helmut Schrott; Eric Vittinghoff; Donald B Hunninghake
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
JAMA : the journal of the American Medical Association 2002;288(1):58-66.
2002: David M Herrington; Eric Vittinghoff; Feng Lin; Josephine Fong; Fran Harris; Donald B Hunninghake; Vera Bittner; Helmut Schrott; Roger S Blumenthal; Robert Levy
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).
Circulation 2002;105(25):2962-7.
2001: William Insull; Michael J Koren; Jean Davignon; D Sprecher; Helmut Schrott; L M Keilson; A S Brown; Carlos A Dujovne; Michael H Davidson; Richard McLain; Therese Heinonen
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
Atherosclerosis 2001;157(1):137-44.
2001: H H Knapp; Helmut Schrott; P Ma; Robert Knopp; B Chin; J M Gaziano; Joanne M Donovan; Steven K Burke; Michael H Davidson
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
The American journal of medicine 2001;110(5):352-60.
2000: Michael H Davidson; Evan A Stein; Donald B Hunninghake; Leiv Ose; Carlos A Dujovne; William Insull; Marcelo C Bertolami; Stuart R Weiss; John J P Kastelein; Russell S Scott; S Campodónico; Ivan D Escobar; Helmut Schrott; Harold E Bays; Michael Stepanavage; M Wu; A C Tate; MR Melino; Debra Kush; Michele Mercuri; Yale B Mitchel
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2000;10(5):253-62.
2000: Adrian S Dobs; Helmut Schrott; Michael H Davidson; Harold E Bays; Evan A Stein; Debra Kush; M Wu; Yale B Mitchel; R D Illingworth
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
Metabolism: clinical and experimental 2000;49(9):1234-8.
2000: Helmut Schrott; Howard R Knapp; M Davila; L Shurzinske; D Black
Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study.
American heart journal 2000;140(2):249-52.
2000: Leiv Ose; Michael H Davidson; Evan A Stein; John J P Kastelein; Russell S Scott; Donald B Hunninghake; S Campodonico; William Insull; Ivan D Escobar; Helmut Schrott; Michael Stepanavage; M Wu; A C Tate; MR Melino; Michele Mercuri; Yale B Mitchel
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
Clinical cardiology 2000;23(1):39-46.
1999: Claudine Legault; Marcia L Stefanick; V T Miller; S M Marcovina; Helmut Schrott
Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: the postmenopausal estrogen/progestins interventions (PEPI) trial.
Journal of clinical epidemiology 1999;52(12):1187-95.
1998: Donald B Hunninghake; RG Bakker-Arkema; J P Wigand; M Drehobl; Helmut Schrott; J L Early; P Abdallah; S McBride; DM Black
Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.
The Journal of family practice 1998;47(5):349-56.
1998: Mark A Espeland; P E Hogan; SE Fineberg; George Howard; Helmut Schrott; MA Waclawiw; Trudy L Bush
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
Diabetes care 1998;21(10):1589-95.
1998: Evan A Stein; Michael H Davidson; Adrian S Dobs; Helmut Schrott; Carlos A Dujovne; Harold E Bays; Stuart R Weiss; MR Melino; Michael Stepanavage; Yale B Mitchel
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
The American journal of cardiology 1998;82(3):311-6.
1998: Michael J Koren; D G Smith; Donald B Hunninghake; Michael H Davidson; James M McKenney; Stuart R Weiss; Helmut Schrott; R W Henley; P Tresh; Richard McLain; RG Bakker-Arkema; DM Black
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
PharmacoEconomics 1998;14(1):59-70.
1998: David M Herrington; J Fong; C T Sempos; D M Black; Helmut Schrott; Pentti M Rautaharju; P S Bachorik; Roger S Blumenthal; S Khan; Nanette K Wenger
Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)
American heart journal 1998;136(1):115-24.
1998: Mark A Espeland; S M Marcovina; V Miller; P D Wood; Carol Wasilauskas; Roger Sherwin; Helmut Schrott; Trudy L Bush
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
Circulation 1998;97(10):979-86.
1997: Michael Davidson; James McKenney; Evan Stein; Helmut Schrott; RG Bakker-Arkema; R Fayyad; D Black
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
The American journal of cardiology 1997;79(11):1475-81.
1997: Helmut Schrott; V Bittner; Eric Vittinghoff; D M Herrington; S Hulley
Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
JAMA : the journal of the American Medical Association 1997;277(16):1281-6.
1996: Elizabeth Barrett-Connor; Helmut Schrott; Gail A Greendale; Donna Kritz-Silverstein; Mark A Espeland; Michael P Stern; T Bush; J A Perlman
Factors associated with glucose and insulin levels in healthy postmenopausal women.
Diabetes care 1996;19(4):333-40.
1995: Helmut Schrott; Evan A Stein; Carlos A Dujovne; Michael H Davidson; G B Goris; T H Oliphant; J C Phillips; G G Shawaryn
Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
The American journal of cardiology 1995;75(1):34-9.
1990: Helmut Schrott; P Palumbo
The cholesterol controversy.
Iowa medicine : journal of the Iowa Medical Society 1990;80(7):349-51.
1980: W L Haskell; H L Taylor; P D Wood; Helmut Schrott; Gerardo Heiss
Strenuous physical activity, treadmill exercise test performance and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study.
Circulation 1980;62(4 Pt 2):IV53-61.